Our Founder, Gene Dolgoff, has a successful track record of building world-changing technologies and companies. He took one of those companies public on NASDAQ, providing early investors an ROI of 3500% in 5 years. He believes the return will be greater here.
Holobeam's first product will be its new advanced portable x-ray system called Holo-X.
The product is expected to be ready for sale by the end of the year (2022). To minimize sales resistance, it will be sold to hospitals, universities, and other clinics by requiring only a small initial deposit, generating revenues on a pay-per-use basis.
Significant revenues are expected from this product during the following years, funding the required development of the company's follow-on products. The follow-on products (the HET MRI scanner and the portable HET scanner) will also be sold on a deposit plus pay-per-use basis.
To minimize competition, the basic engines for these two products will be sold, along with a technology license, to the major manufacturers of diagnostic and therapeutic hardware systems.
Holobeam is currently seeking to raise only $2 million, because with this amount we can complete development of our Holo-X portable x-ray scanner product and make it ready for sale. Based on market studies and inquiries we have determined that this product will have an immediate large market and be very profitable. The produced profits will enable us to fund development completion of our other products without the need for additional fund-raising efforts.
If you are interested in investing in Holobeam to help make these technologies a reality, fill out this form and we will get back to you as soon as possible.